~ Buy the ADVIL ALLERGY SINUS (chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

ADVIL ALLERGY SINUS Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Advil Allergy Sinus patents expire, and what generic alternatives are available?

Advil Allergy Sinus is a drug marketed by Haleon Us Holdings and is included in one NDA. There is one patent protecting this drug.

This drug has thirty-four patent family members in eighteen countries.

The generic ingredient in ADVIL ALLERGY SINUS is chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride profile page.

DrugPatentWatch^® Generic Entry Outlook for Advil Allergy Sinus

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be February 28, 2027. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ADVIL ALLERGY SINUS?
What are the global sales for ADVIL ALLERGY SINUS?
What is Average Wholesale Price for ADVIL ALLERGY SINUS?

Summary for ADVIL ALLERGY SINUS

International Patents:	34
US Patents:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	3
Patent Applications:	15
What excipients (inactive ingredients) are in ADVIL ALLERGY SINUS?	ADVIL ALLERGY SINUS excipients list
DailyMed Link:	ADVIL ALLERGY SINUS at DailyMed

Drug patent expirations by year for ADVIL ALLERGY SINUS

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for ADVIL ALLERGY SINUS

Generic Entry Date for ADVIL ALLERGY SINUS^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: ⤷ Sign Up NDA: 021441 Dosage: TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for ADVIL ALLERGY SINUS

Drug Class	Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug alpha-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists

US Patents and Regulatory Information for ADVIL ALLERGY SINUS

ADVIL ALLERGY SINUS is protected by one US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of ADVIL ALLERGY SINUS is ⤷ Sign Up.

This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting ADVIL ALLERGY SINUS

Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Haleon Us Holdings	ADVIL ALLERGY SINUS	chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride	TABLET;ORAL	021441-001	Dec 19, 2002		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for ADVIL ALLERGY SINUS

See the table below for patents covering ADVIL ALLERGY SINUS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Hong Kong	1166602	COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES	⤷ Sign Up
Mexico	PA05006331	COMPOSICIONES DE FARMACOS ANTI-INFLAMATORIOS NO ESTEROIDEOS DESCONGESTIONANTES Y ANTI-HISTAMINICOS. (COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES.)	⤷ Sign Up
Russian Federation	2005122403	КОМПОЗИЦИИ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ПРОТИВОЗАСТОЙНЫХ СРЕДСТВ И АНТИГИСТАМИНОВ	⤷ Sign Up
Canada	2508611	COMPOSITIONS DE MEDICAMENTS ANTI-INFLAMMATOIRES NON-STEROIDAUX, DECONGESTIONNANTS ET ANTIHISTAMINIQUES (COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES)	⤷ Sign Up
New Zealand	552030	Multi-layer tablet comprising non-steroidal anti-inflammatory drugs decongestants and non-sedating antihistamines	⤷ Sign Up
Chile	2003002653	COMPOSICION FARMACEUTICA QUE COMPRENDE (A) UN ANTIINFLAMATORIO NO ESTEROIDAL (NSAID), PREFERENTEMENTE IBUPROFENO, (B) UN DESCONGESTIONANTE, PREFERENTEMENTE PSEUDOEFEDRINA Y (C) UN ANTIHISTAMINICO, PREFERENTEMENTE CLORFENIRAMINA; METODO PARA SU PREPAR	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration